Matías J Alet: On the Implementation of Tenecteplase for Acute Ischemic Stroke at ESOC 2026
Matías J Alet, Member of Education Committee of World Stroke Organization, shared on LinkedIn:
”I was honored to participate in ESOC 2026 in Maastricht as part of the industry-sponsored satellite symposium ‘Opportunities for improving AIS patient outcomes’.
My talk, ‘Switching to TNK: the real-world experience’, focused on the implementation of tenecteplase for acute ischemic stroke, including international real-world evidence and early lessons from Argentina.
This transition is an opportunity to revisit hyperacute stroke workflows: simplifying administration, reducing treatment delays, improving transfer logistics, and strengthening local quality monitoring.
I am grateful to Boehringer Ingelheim for the invitation.
It was a privilege to share the Argentine perspective in such an important international forum.”

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support